Safety Alerts Saves Lives
Safety Alerts  
Home Privacy About Us Contact Us Change Preferences
" "
Safety Alerts
August 17, 1999

RIJ Pharmaceutical Recalls Losopan Antacid

Middletown, NY (SafetyAlerts) - The Food and Drug Administration (FDA) today reported that RIJ Pharmaceutical Corporation is recalling Losopan Antacid because of mislabeling.  Some bottles bear an incorrect antacid back label (Goldline Genaton).

Losopan Antacid (Magaldrate Oral Suspension Antacid 540 mg/5mL, in 12 fluid ounce bottles, OTC indicated for the relief of heartburn, sour stomach and/or acid indigestion and upset stomach associated with these symptoms.NDC #0182-6078-39.

Recall #D-302-9.

Lot #81235 EXP 12/00.

RIJ Pharmaceutical Corporation, Middletown, New York.

Manufacturer, by letter and fax dated July 21, 1999. Firm-initiated recall ongoing.


5,208 bottles were distributed.


The information contained herein has been obtained from sources that the Company believes to be reliable, however, the Company has not independently verified or confirmed the information and the recipient acknowledges that no representations or warranties are being made in connection with the use of the information.